<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Cardiovascular Medicine</title><link href="http://www.aboutprescriptiondrugs.com/topic/Cardiovascular%20Medicine" rel="alternate"></link><id>http://www.aboutprescriptiondrugs.com/topic/Cardiovascular Medicine</id><updated>2010-03-16T12:32:13Z</updated><entry><title>Hospice Defibrillators</title><link href="http://www.aboutprescriptiondrugs.com/photo/2195534" rel="alternate"></link><updated>2010-03-15T13:18:25Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/photo/2195534</id><summary type="html">This Aug. 2008 handout photo provided by &lt;a title="Carol Filak" href="/topic/Carol+Filak" &gt;Carol Filak&lt;/a&gt; shows &lt;a title="Joseph Hoffman" href="/topic/Joseph+Hoffman" &gt;Joseph Hoffman&lt;/a&gt; of &lt;a title="West Orange" href="/topic/West+Orange" &gt;West Orange&lt;/a&gt;, &lt;a title="New Jersey" href="/topic/New+Jersey" &gt;N.J.&lt;/a&gt;, with his daughter Carol Filak of &lt;a title="Clifton" href="/topic/Clifton" &gt;Clifton&lt;/a&gt;, Va. Filak had to repeatedly ask her father's cardiologist to turn off his implanted defibrillato...</summary><category term="Medical Devices"></category><category term="Clifton"></category><category term="West Orange"></category><category term="Cardiovascular Medicine"></category><category term="Joseph Hoffman"></category><category term="Carol Filak"></category></entry><entry><title>Retired NFL players' arteries may not be so healthy</title><link href="http://www.aboutprescriptiondrugs.com/article/Retired%20NFL%20players%27%20arteries%20may%20not%20be%20so%20healthy" rel="alternate"></link><updated>2010-03-16T12:32:13Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Retired%20NFL%20players%27%20arteries%20may%20not%20be%20so%20healthy</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Despite all their hard work on the field, retired &lt;a title="National Football League" href="/topic/National+Football+League" &gt;National Football League&lt;/a&gt; players may be facing the same health problems that plague obese men who stick to watching the game.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;"We see these guys as supermen, they are the pinnacle of health," said &lt;a title="R. Todd Hurst" href="/topic/R.+...</summary><category term="Jobs and Labor"></category><category term="Workplace Safety"></category><category term="Football"></category><category term="Professional Football"></category><category term="Reuters Group plc"></category><category term="Hurst"></category><category term="Cardiovascular Medicine"></category><category term="Marc Miller"></category><category term="R. Todd Hurst"></category><category term="Sherry Baron"></category><category term="National Football League Association"></category></entry><entry><title>Women die more often than men from heart disease: study</title><link href="http://www.aboutprescriptiondrugs.com/article/Women%20die%20more%20often%20than%20men%20from%20heart%20disease%3A%20study" rel="alternate"></link><updated>2010-03-16T12:16:08Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Women%20die%20more%20often%20than%20men%20from%20heart%20disease%3A%20study</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Women die more often than men from heart disease because they are not systematically given the same treatment and tests, according to a French study unveiled here Tuesday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The study, carried out on 3,000 women in the French region of &lt;a title="Franche-Comte" href="/topic/Franche-Comte" &gt;Franche-Comte&lt;/a&gt; in 2006 and 2007, found that those hospitalized after suffering a cardiac attack were less frequently given an angiograph to study the heart's vessels.&amp;lt;/...</summary><category term="Women's Health"></category><category term="Besancon"></category><category term="Franche-Comte"></category><category term="Cardiovascular Medicine"></category><category term="Francois Schiele"></category></entry><entry><title>FDA questions new use for Boston Science device</title><link href="http://www.aboutprescriptiondrugs.com/article/FDA%20questions%20new%20use%20for%20Boston%20Science%20device" rel="alternate"></link><updated>2010-03-16T11:46:01Z</updated><author><name>AP Features</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/FDA%20questions%20new%20use%20for%20Boston%20Science%20device</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; said Tuesday a heart device from &lt;a title="Boston Scientific Corporation" href="/topic/Boston+Scientific+Corporation" &gt;Boston Scientific&lt;/a&gt; appears effective for a new group of patients, though questions remain about the accuracy of the company's study of the device.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Boston Scientific has asked the FDA to approve its heart rhythm device t...</summary><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Boston Scientific Corporation"></category><category term="St. Jude Medical Inc."></category><category term="Natick"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Long-term safety of drug-coated stents questioned</title><link href="http://www.aboutprescriptiondrugs.com/article/Long-term%20safety%20of%20drug-coated%20stents%20questioned" rel="alternate"></link><updated>2010-03-16T11:15:38Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Long-term%20safety%20of%20drug-coated%20stents%20questioned</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Atlanta" href="/topic/Atlanta" &gt;ATLANTA&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - New research shows more patients who got drug-coated stents right after suffering a severe heart attack later died from heart-related problems than those who received older, cheaper bare-metal models.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Seven years after the first drug-coated stent was approved in the &lt;a title="United States" href="/topic/United+States" &gt;United St...</summary><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Medical Equipment and Supplies"></category><category term="Reuters Group plc"></category><category term="Boston Scientific Corporation"></category><category term="Abbott Laboratories Inc."></category><category term="University of Copenhagen"></category><category term="John Wallace"></category><category term="Richard Chang"></category><category term="Cardiovascular Medicine"></category><category term="Debra Sherman"></category><category term="Peter Clemmensen"></category></entry><entry><title>Doctor says heart groups too cozy with industry</title><link href="http://www.aboutprescriptiondrugs.com/article/Doctor%20says%20heart%20groups%20too%20cozy%20with%20industry" rel="alternate"></link><updated>2010-03-16T10:45:33Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Doctor%20says%20heart%20groups%20too%20cozy%20with%20industry</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Doctor accuses Heart Association, &lt;a title="Cardiology College" href="/topic/Cardiology+College" &gt;Cardiology College&lt;/a&gt;, of letting industry influence policy&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;A prominent cardiologist accused leading heart organizations of being too cozy with industry and allowing those ties to influence its policies and education programs for doctors.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;&lt;a title="The Cleveland Clinic" href="/topic/The+Cleveland+Clinic" &gt;Cleveland Clinic&lt;/a&gt;...</summary><category term="Food and Cooking"></category><category term="Beverages"></category><category term="Soft Drinks"></category><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Education Policy"></category><category term="Education"></category><category term="Education Issues"></category><category term="Coca-Cola Classic"></category><category term="Diet Coke"></category><category term="Baylor University"></category><category term="Robert Harrington"></category><category term="Steven Nissen"></category><category term="Jack Lewin"></category><category term="Cardiovascular Medicine"></category><category term="Cardiology College"></category></entry><entry><title>Women more likely to die after heart attack: study</title><link href="http://www.aboutprescriptiondrugs.com/article/Women%20more%20likely%20to%20die%20after%20heart%20attack%3A%20study" rel="alternate"></link><updated>2010-03-16T10:00:09Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Women%20more%20likely%20to%20die%20after%20heart%20attack%3A%20study</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Atlanta" href="/topic/Atlanta" &gt;ATLANTA&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - When it comes to matters of the heart, women should be treated more like men.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Among patients admitted to the hospital for a heart attack, women were far less likely than men to get angiography in which blood vessels are injected with dye so that blockages are visible on an X-ray, or angioplasty to clear blockages, a study found....</summary><category term="Heart Attacks"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Women's Health"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Medical Imaging and Diagnostics"></category><category term="Cardiovascular Medicine"></category><category term="Debra Sherman"></category><category term="Francois Schiele"></category><category term="University Hospital of Besancon"></category><category term="Marcelo Di Carli"></category></entry><entry><title>Gene test 'helps pinpoint right dose of heart drug'</title><link href="http://www.aboutprescriptiondrugs.com/article/Gene%20test%20%27helps%20pinpoint%20right%20dose%20of%20heart%20drug%27" rel="alternate"></link><updated>2010-03-16T09:17:13Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Gene%20test%20%27helps%20pinpoint%20right%20dose%20of%20heart%20drug%27</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;A simple genetic test can help pinpoint the precise dose of a potentially life-saving medication taken by millions to ward off blood clotting after heart surgery, a study published Tuesday found.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The clinical study led by two leading medical researchers -- &lt;a title="Medco Research Institute" href="/topic/Medco+Research+Institute" &gt;Medco Research Institute&lt;/a&gt; specializing in pharmacy care, and the &lt;a title="Mayo Foundation for Medical Education and Research"...</summary><category term="Health Care Issues"></category><category term="Genetic Testing"></category><category term="Vascular Disorders"></category><category term="Venous Disorders"></category><category term="Robert Epstein"></category><category term="Cardiovascular Medicine"></category><category term="Medco Research Institute"></category></entry><entry><title>Gene test helps pinpoint right dose of heart drug: report</title><link href="http://www.aboutprescriptiondrugs.com/article/Gene%20test%20helps%20pinpoint%20right%20dose%20of%20heart%20drug%3A%20report" rel="alternate"></link><updated>2010-03-16T09:16:32Z</updated><author><name>AFP American Edition</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Gene%20test%20helps%20pinpoint%20right%20dose%20of%20heart%20drug%3A%20report</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;A simple genetic test can help pinpoint the precise dose of a potentially life-saving medication taken by millions to ward off blood clotting after heart surgery, a study published Tuesday found.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The clinical study led by two leading medical researchers -- &lt;a title="Medco Research Institute" href="/topic/Medco+Research+Institute" &gt;Medco Research Institute&lt;/a&gt; specializing in pharmacy care, and the &lt;a title="Mayo Foundation for Medical Education and Research"...</summary><category term="Health Care Issues"></category><category term="Genetic Testing"></category><category term="Vascular Disorders"></category><category term="Venous Disorders"></category><category term="Robert Epstein"></category><category term="Cardiovascular Medicine"></category><category term="Medco Research Institute"></category><category term="Medco Research"></category></entry><entry><title>Women more likely to die after heart attack</title><link href="http://www.aboutprescriptiondrugs.com/article/Women%20more%20likely%20to%20die%20after%20heart%20attack" rel="alternate"></link><updated>2010-03-16T06:00:46Z</updated><author><name>Reuters Life! Online Report</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Women%20more%20likely%20to%20die%20after%20heart%20attack</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Atlanta" href="/topic/Atlanta" &gt;ATLANTA&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - When it comes to matters of the heart, women should be treated more like men.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;A large study found that among patients admitted to the hospital for a heart attack, women were far less likely than men to get angiography to find vessel blockages or angioplasty to clear them.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Women were about twice as likely as men...</summary><category term="Heart Attacks"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Medical Imaging and Diagnostics"></category><category term="Cardiovascular Medicine"></category><category term="Debra Sherman"></category></entry><entry><title>Novartis drug fails to help after heart attack: study</title><link href="http://www.aboutprescriptiondrugs.com/article/Novartis%20drug%20fails%20to%20help%20after%20heart%20attack%3A%20study" rel="alternate"></link><updated>2010-03-16T05:15:37Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Novartis%20drug%20fails%20to%20help%20after%20heart%20attack%3A%20study</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Atlanta" href="/topic/Atlanta" &gt;ATLANTA&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - The addition of the &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis&lt;/a&gt; blood pressure medicine &lt;a title="Tekturna" href="/topic/Tekturna" &gt;Tekturna&lt;/a&gt; to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worsening of its blood pumping ability, according to data from a st...</summary><category term="Vascular Disorders"></category><category term="High Blood Pressure"></category><category term="Reuters Group plc"></category><category term="Tekturna"></category><category term="Scott Solomon"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Heart-shock device may disrupt quiet hospice death</title><link href="http://www.aboutprescriptiondrugs.com/article/Heart-shock%20device%20may%20disrupt%20quiet%20hospice%20death" rel="alternate"></link><updated>2010-03-16T00:30:13Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-16:/article/Heart-shock%20device%20may%20disrupt%20quiet%20hospice%20death</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;HEALTHBEAT: Hospices slow to help patients decide when to switch off heart-shocking implants&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;If you have a heart-zapping defibrillator implanted in your chest but now are dying of something else, when do you have it turned off?&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Carol Filak had heard about painful, repeated shocks that people sometimes experience from those implants in their final days. So when her father, &lt;a title="Joseph Hoffman" href="/topic/Joseph+Hoffm...</summary><category term="Health Care Issues"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="The Associated Press"></category><category term="Clifton"></category><category term="Lauran Neergaard"></category><category term="West Orange"></category><category term="Kenneth Ellenbogen"></category><category term="End of Life Decisions"></category><category term="Cardiovascular Medicine"></category><category term="Annals of Internal Medicine"></category><category term="Nathan Goldstein"></category><category term="Joseph Hoffman"></category><category term="Palliative Care Organization"></category><category term="Virginia Commonwealth University School"></category></entry><entry><title>Boston Scientific suspends defibrillator sales</title><link href="http://www.aboutprescriptiondrugs.com/article/Boston%20Scientific%20suspends%20defibrillator%20sales" rel="alternate"></link><updated>2010-03-15T16:30:12Z</updated><author><name>AP Features</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/Boston%20Scientific%20suspends%20defibrillator%20sales</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Medical device maker &lt;a title="Boston Scientific Corporation" href="/topic/Boston+Scientific+Corporation" &gt;Boston Scientific&lt;/a&gt; said Monday it is suspending sales of its heart-shocking defibrillator implants after failing to alert regulators to changes in manufacturing of the best-selling devices.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The company said it uncovered two production changes that were not cleared with the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administrat...</summary><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Boston Scientific Corporation"></category><category term="The Associated Press"></category><category term="Jude Thaddeus"></category><category term="David Lewis"></category><category term="Sanford C. Bernstein &amp; Co. LLC"></category><category term="St. Jude Medical Inc."></category><category term="Natick"></category><category term="Tom Murphy"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Summary Box: High-dose Lipitor lessens heart risk</title><link href="http://www.aboutprescriptiondrugs.com/article/Summary%20Box%3A%20High-dose%20Lipitor%20lessens%20heart%20risk" rel="alternate"></link><updated>2010-03-15T15:30:33Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/Summary%20Box%3A%20High-dose%20Lipitor%20lessens%20heart%20risk</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Summary Box: &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; study finds high-dose &lt;a title="Lipitor" href="/topic/Lipitor" &gt;Lipitor&lt;/a&gt; cuts heart risk in riskier patients&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;NEW LIPITOR DATA: In some heart patients, the highest dose of Lipitor cut risk of heart attack and other complications by a third, compared to the lowest dose.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;PATIENT POPULATION: Patients in this new data analysis had heart disease, kidney...</summary><category term="Kidney Failure"></category><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Vascular Disorders"></category><category term="High Blood Pressure"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Kidney and Urologic Health"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Pfizer: More Lipitor cuts heart complications more</title><link href="http://www.aboutprescriptiondrugs.com/article/Pfizer%3A%20More%20Lipitor%20cuts%20heart%20complications%20more" rel="alternate"></link><updated>2010-03-15T15:00:39Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/Pfizer%3A%20More%20Lipitor%20cuts%20heart%20complications%20more</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;&lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt;: Study finds high &lt;a title="Lipitor" href="/topic/Lipitor" &gt;Lipitor&lt;/a&gt; dose cuts chances of heart complications over low dose&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;A reanalysis of research data found a high dose of popular cholesterol pill Lipitor lowers risk of heart attack and stroke in some patients with both heart disease and kidney disease, the drug's maker said Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Pfizer Inc. said the new...</summary><category term="Kidney Failure"></category><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Kidney and Urologic Health"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Arteries improve after smokers quit, study finds</title><link href="http://www.aboutprescriptiondrugs.com/article/Arteries%20improve%20after%20smokers%20quit%2C%20study%20finds" rel="alternate"></link><updated>2010-03-15T14:15:53Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/Arteries%20improve%20after%20smokers%20quit%2C%20study%20finds</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Arteries, cholesterol improve soon after smokers quit, even if they gain weight, study finds&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Quitting smoking can turn back time.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;A year after kicking the habit, smokers' arteries showed signs of reversing a problem that can set the stage for heart disease, according to the first big study to test this.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The improvement came even though smokers gained an average of 9 pounds after they quit, researchers fou...</summary><category term="Health Care Issues"></category><category term="Alfred Bove"></category><category term="James Stein"></category><category term="Cardiovascular Medicine"></category><category term="Smoking and Tobacco Use"></category></entry><entry><title>Impotence plus heart disease ups death risk: study</title><link href="http://www.aboutprescriptiondrugs.com/article/Impotence%20plus%20heart%20disease%20ups%20death%20risk%3A%20study" rel="alternate"></link><updated>2010-03-15T13:18:04Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/Impotence%20plus%20heart%20disease%20ups%20death%20risk%3A%20study</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Men with heart disease who also complain of erectile dysfunction die sooner than other male heart patients, researchers reported on Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;They found that men who had both conditions were twice as likely to die from any cause and twice as likely to have a heart attack than men with heart disease alone.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The researchers expressed concern that using drugs...</summary><category term="Heart Attacks"></category><category term="Vascular Disorders"></category><category term="Atherosclerosis"></category><category term="Sexual and Reproductive Health"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Men's Health"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Cardiovascular Medicine"></category><category term="Male Sexual Dysfunction"></category><category term="Cleveland (Ohio)"></category><category term="Michael Bohm"></category><category term="University of Saarland"></category></entry><entry><title>Adding fat-lowering drug no help for diabetic hearts</title><link href="http://www.aboutprescriptiondrugs.com/article/Adding%20fat-lowering%20drug%20no%20help%20for%20diabetic%20hearts" rel="alternate"></link><updated>2010-03-15T13:16:11Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/Adding%20fat-lowering%20drug%20no%20help%20for%20diabetic%20hearts</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Atlanta" href="/topic/Atlanta" &gt;ATLANTA&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The study run by the &lt;a title="National Institutes of Health" href="/topic/Na...</summary><category term="Cholesterol"></category><category term="Vascular Disorders"></category><category term="High Blood Pressure"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Stroke"></category><category term="Reuters Group plc"></category><category term="Steven Nissen"></category><category term="Cardiovascular Medicine"></category><category term="Brain and Nerve Health"></category><category term="Eugene Sun"></category><category term="Henry Ginsberg"></category><category term="Denise Simons-Morton"></category></entry><entry><title>African Americans get fewer heart-protecting drugs</title><link href="http://www.aboutprescriptiondrugs.com/article/African%20Americans%20get%20fewer%20heart-protecting%20drugs" rel="alternate"></link><updated>2010-03-15T12:17:17Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/African%20Americans%20get%20fewer%20heart-protecting%20drugs</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Even within the Veterans Affairs health system, where everyone should have the same access to care, African Americans are less likely than their white counterparts to be prescribed heart-protecting medications or undergo bypass surgery to treat blocked heart arteries, a new study finds.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The findings, based on data for nearly 475,000 VA patients, found that African A...</summary><category term="Health Care Issues"></category><category term="Cholesterol"></category><category term="Social Issues"></category><category term="Racial Issues"></category><category term="African-American Issues"></category><category term="Reuters Group plc"></category><category term="Little Rock"></category><category term="University of Arkansas for Medical Sciences"></category><category term="Cardiovascular Medicine"></category><category term="Jawahar Mehta"></category></entry><entry><title>Tissue-freezing balloon beats drugs in ablation study</title><link href="http://www.aboutprescriptiondrugs.com/article/Tissue-freezing%20balloon%20beats%20drugs%20in%20ablation%20study" rel="alternate"></link><updated>2010-03-15T10:17:45Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-15:/article/Tissue-freezing%20balloon%20beats%20drugs%20in%20ablation%20study</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;An experimental ablation therapy system that freezes heart tissue with a balloon catheter to treat a common heart rhythm disorder is far more effective than drug therapy, a study found Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Researchers compared the safety and efficacy of the Arctic Front CryoAblation Catheter System produced by US firm &lt;a title="Medtronic Inc." href="/topic/Medtronic+Inc." &gt;Medtronic&lt;/a&gt; to drug therapy over at least one year in 245 patients in the &lt;a title="United States...</summary><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Oceania"></category><category term="Cardiovascular Medicine"></category><category term="Douglas Packer"></category></entry></feed>